Fatemeh Yazdi Samadi
Overview
Explore the profile of Fatemeh Yazdi Samadi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yousefi M, Ghahremanzadeh R, Nejadmoghaddam M, Samadi F, Najafzadeh S, Fatideh F, et al.
Future Sci OA
. 2024 Jun;
10(1):FSO921.
PMID: 38827799
Here, an innovative kind of antibacterial nanocomposite film is developed by incorporating graphene oxide and zinc oxide into chitosan matrix. Our dressing was fabricated using the solution casting method. Fourier...
2.
Neissari N, Shahedi M, Habibi Z, Yousefi M, Minai-Tehrani A, Samadi F, et al.
Org Biomol Chem
. 2023 May;
21(23):4846-4853.
PMID: 37249163
A multicomponent enzyme-catalyzed process is suggested for the synthesis of a novel series of 1,3,4-oxadiazole thioether derivatives with yields ranging from 65 to 94%. Novozym 435, the immobilized form of...
3.
Montazeri S, Rastegari A, Mohammadi Z, Nazari M, Yousefi M, Samadi F, et al.
IET Nanobiotechnol
. 2023 Feb;
17(3):204-211.
PMID: 36734307
Epidermal growth factor (EGF) can be efficiently used in wound healing process; but the main obstacle of its clinical use is its susceptibility to proteolysis and maintaining its effective concentration...
4.
Shahedi M, Shahani R, Habibi Z, Yousefi M, Brask J, Minaei-Tehrani A, et al.
Sci Rep
. 2022 Dec;
12(1):22326.
PMID: 36567332
A mild and efficient method was developed for the synthesis of new derivatives of thiazolo[3,2-a] pyrimidin-3(2H)-ones from available starting materials based on the oxidation of catechols to ortho-quinone by Myceliophthora...
5.
Mohammadi Z, Samadi F, Rahmani S, Mohammadi Z
Daru
. 2020 Jul;
28(2):433-442.
PMID: 32656689
Background: treatment of breast cancer as one of the most common cancers in the world remains an important area of drug development based on nanoparticulate systems. Effective targeted therapy of...
6.
Rahmani S, Hakimi S, Esmaeily A, Samadi F, Mortazavian E, Nazari M, et al.
Int J Pharm
. 2019 Feb;
560:306-314.
PMID: 30797073
The present study aimed to investigate in vitro DNA transfection efficiency of three novel chitosan derivatives: thiolated trimethyl chitosan (TMC-Cys), methylated 4-N,N dimethyl aminobenzyl N,O carboxymethyl chitosan(MABCC) and thiolated trimethyl...
7.
Sedghi R, Shaabani A, Mohammadi Z, Samadi F, Isaei E
Carbohydr Polym
. 2017 Jan;
159:1-10.
PMID: 28038737
In this study, an electrospinning technique was used for the fabrication of novel biomedicated nanofibers which are applied for preventing wound infections and local chemotherapy. CURs containing nanofibers with a...
8.
Hakimi S, Mortazavian E, Mohammadi Z, Samadi F, Samadikhah H, Taheritarigh S, et al.
Int J Biol Macromol
. 2016 Nov;
95:574-581.
PMID: 27867054
Chitosan is a natural mucoadhesive, biodegradable, biocompatible and nontoxic polymer which has been used in pharmaceutical industry for a lot of purposes such as dissolution enhancing, absorption enhancing, sustained releasing...
9.
Samadi F, Mohammadi Z, Yousefi M, Majdejabbari S
Int J Biol Macromol
. 2015 Nov;
82:599-606.
PMID: 26552018
Chitosan is a biocompatible, non-toxic and biodegradable biopolymer. Due to the presence of functional groups on its surface, it can be modified and used as a carrier in targeted drug/gene...